{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:24:53Z","timestamp":1787765093924,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 095059"],"award-info":[{"award-number":["DK 095059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.isci.2023.108631","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T11:29:04Z","timestamp":1701516544000},"page":"108631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation"],"prefix":"10.1016","volume":"27","author":[{"given":"Sagar","family":"Bhayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5778-1512","authenticated-orcid":false,"given":"Julie A.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kamigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranga","family":"Wijeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda P.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn J.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Smoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.108631_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic Differences in Childhood Nephrotic Syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.isci.2023.108631_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.isci.2023.108631_bib4","article-title":"Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.108631_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/nep.13582","article-title":"Spectrum of biopsy-proven renal disease in northern India: A single-centre study","volume":"25","author":"Mittal","year":"2020","journal-title":"Nephrology"},{"key":"10.1016\/j.isci.2023.108631_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986\u20132015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.108631_bib8","first-page":"1","article-title":"Deaths: Final Data for 2017","volume":"68","author":"Kochanek","year":"2019","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.isci.2023.108631_bib9","series-title":"Clinical Pediatric Nephrology K","first-page":"182","article-title":"Nephrotic Syndrome","author":"Valentini","year":"2007"},{"key":"10.1016\/j.isci.2023.108631_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2012.115","article-title":"Childhood nephrotic syndrome--current and future therapies","volume":"8","author":"Greenbaum","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","article-title":"Management patterns of childhood-onset nephrotic syndrome","volume":"24","author":"MacHardy","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","article-title":"Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?","volume":"34","author":"Ponticelli","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.isci.2023.108631_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2023.108631_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.111.071654","article-title":"Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects","volume":"80","author":"Agrawal","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.isci.2023.108631_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1681\/ASN.2014111080","article-title":"Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor gamma Essential for Resistance to Crescentic GN","volume":"27","author":"Henique","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1797.2009.01146.x","article-title":"Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection","volume":"15","author":"Liu","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.isci.2023.108631_bib17","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/sj.ki.5000336","article-title":"Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis","volume":"69","author":"Yang","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ndt\/gfr240","article-title":"Protective effects of PPARgamma agonist in acute nephrotic syndrome","volume":"27","author":"Zuo","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.isci.2023.108631_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41581-020-00339-6","article-title":"Nuclear receptors in podocyte biology and glomerular disease","volume":"17","author":"Agrawal","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00467-022-05637-8","article-title":"Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome","volume":"38","author":"Hunley","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.ajkd.2009.11.013","article-title":"Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis","volume":"55","author":"Sarafidis","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.isci.2023.108631_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep24392","article-title":"Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.108631_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2023.108631_bib24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/sj.ki.5001965","article-title":"Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in\u00a0vitro and in\u00a0vivo","volume":"70","author":"Marshall","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-811X-8-8","article-title":"PDZ domains and their binding partners: structure, specificity, and modification","volume":"8","author":"Lee","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2023.108631_bib26","doi-asserted-by":"crossref","DOI":"10.1242\/dev.164038","article-title":"Single-cell Analysis of Progenitor Cell Dynamics and Lineage Specification in the Human Fetal Kidney","volume":"145","author":"Menon","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.isci.2023.108631_bib27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nsb956","article-title":"The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators","volume":"10","author":"Aviv","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.isci.2023.108631_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S1097-2765(03)00178-3","article-title":"RNA recognition via the SAM domain of Smaug","volume":"11","author":"Green","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2023.108631_bib29","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2023.108631_bib30","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.108631_bib31","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2353\/ajpath.2010.090746","article-title":"A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue","volume":"177","author":"Hodgin","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2023.108631_bib32","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2023.108631_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib34","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2215\/CJN.13791215","article-title":"The Players: Cells Involved in Glomerular Disease","volume":"11","author":"Kitching","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1681\/ASN.2018030238","article-title":"A Single-Cell Transcriptome Atlas of the Mouse Glomerulus","volume":"29","author":"Karaiskos","year":"2018","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108620","article-title":"Nephrotic range proteinuria associated with focal segmental glomerulosclerosis reversed with pioglitazone therapy in a patient with Dunnigan type lipodystrophy","volume":"172","author":"Sharma","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.isci.2023.108631_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/meta.2001.26703","article-title":"Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria","volume":"50","author":"Nakamura","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2023.108631_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4158\/EP11378.OR","article-title":"Podocyte as a potential target of inflammation: role of pioglitazone hydrochloride in patients with type 2 diabetes","volume":"18","author":"Xing","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.isci.2023.108631_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ki.1994.311","article-title":"Treatment of the nephrotic syndrome associated with primary glomerulonephritis","volume":"46","author":"Ponticelli","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1681\/ASN.2021050654","article-title":"Too Little or Too Much? Extracellular Matrix Remodeling in Kidney Health and Disease","volume":"32","author":"Clotet-Freixas","year":"2021","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00784353","article-title":"Alterations in the extracellular matrix components in human glomerular diseases","volume":"415","author":"Oomura","year":"1989","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"10.1016\/j.isci.2023.108631_bib42","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1681\/ASN.2019070696","article-title":"Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis","volume":"31","author":"Merchant","year":"2020","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2023.108631_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.kint.2017.06.028","article-title":"Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease","volume":"93","author":"Rebholz","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1750-3639.2009.00270.x","article-title":"Galectins and gliomas","volume":"20","author":"Le Mercier","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.isci.2023.108631_bib46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.bbrc.2004.10.181","article-title":"Multifaceted role of galectin-3 on human glioblastoma cell motility","volume":"325","author":"Debray","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2023.108631_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ydbio.2008.01.022","article-title":"Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity","volume":"316","author":"Pozzi","year":"2008","journal-title":"Dev. Biol."},{"key":"10.1016\/j.isci.2023.108631_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.V12188","article-title":"Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix","volume":"12","author":"Martin","year":"2001","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040776","article-title":"MMP-2 and 9 in Chronic Kidney Disease","volume":"18","author":"Cheng","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2023.108631_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2019.09.009","article-title":"Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics","volume":"5","author":"Agrawal","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.isci.2023.108631_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ekir.2021.11.037","article-title":"Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation","volume":"7","author":"Bauer","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.isci.2023.108631_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0036-1586228","article-title":"The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis","volume":"43","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.isci.2023.108631_bib53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1053\/ajkd.2002.31986","article-title":"Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis","volume":"39","author":"Hamano","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.isci.2023.108631_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2023.108631_bib55","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Adler","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: clinical course and response to therapy","volume":"23","author":"Korbet","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.isci.2023.108631_bib57","doi-asserted-by":"crossref","first-page":"c75","DOI":"10.1159\/000093993","article-title":"Immunosuppressive Treatment of Idiopathic Focal Segmental Glomerulosclerosis: A Five-Year Follow-Up Study","volume":"104","author":"Goumenos","year":"2006","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.isci.2023.108631_bib58","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10157-018-1585-z","article-title":"Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria","volume":"22","author":"Huang","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib59","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz252","article-title":"Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis","volume":"105","author":"Zhou","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2023.108631_bib60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ki.2014.196","article-title":"Albumin-induced podocyte injury and protection are associated with regulation of COX-2","volume":"86","author":"Agrawal","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2023.108631_bib61","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI118723","article-title":"Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome","volume":"97","author":"Smoyer","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2023.108631_bib62","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2215\/CJN.08370812","article-title":"Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE)","volume":"8","author":"Barisoni","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib63","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2215\/CJN.11951214","article-title":"Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa","volume":"10","author":"Osafo","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10157-006-0421-z","article-title":"Gene expression profiling analysis in nephrology: towards molecular definition of renal disease","volume":"10","author":"Yasuda","year":"2006","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.isci.2023.108631_bib65","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2337\/db06-0477","article-title":"Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy","volume":"55","author":"Schmid","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2023.108631_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223027086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223027086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:00:40Z","timestamp":1787763640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223027086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2589004223027086"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.108631","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.108631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108631"}}